Skip to main content
Caplight Logo









mAbsolve Ltd.

mAbsolve Ltd.

Private
OxfordHealthcare & Life Scienceshttps://mabsolve.com

Last Round

Seed

Mar 3, 2020

Total Funding Raised

$179,000

Company Overview

mAbsolve Ltd. operates in Healthcare & Life Sciences and is based in Oxford. Its latest recorded funding round was a Seed round in March 2020.

mAbsolve Ltd. is a biotechnology company that develops and licenses its proprietary STR Fc silencing technology to improve the safety and effectiveness of therapeutic antibodies and Fc fusion proteins.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

mAbsolve Ltd. Comparables

Compare mAbsolve Ltd. with similar companies based on industry and business-model similarity.

mAbsolve Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
CROSSPOINT Therapeutics
86%
AbFinder Therapeutics Co., Ltd.
65%
Vector Laboratories
64%
Book a demo to see all comparables

For institutional investors. Book with your work email.

mAbsolve Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 3, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Ian Wilkinson

Co-Founder and Chief Scientific Officer

Founding Team

Geoff Hale

Chief Executive Officer

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 20, 2026

    Monthly visitors grew 162% MoM, reaching 2.5K.

  • Nov 9, 2025

    Monthly visitors increased 122% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

mAbsolve Ltd. Filings

Explore SEC and related filing metadata, where available.

mAbsolve Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about mAbsolve Ltd.'s valuation, stock price, and market status.

Is mAbsolve Ltd. a public or private company?

mAbsolve Ltd. is a private company.

What is the current stock price of mAbsolve Ltd.?

mAbsolve Ltd. is a private company, so its shares have no public market price. Caplight tracks mAbsolve Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is mAbsolve Ltd. worth (valuation)?

Valuation information for mAbsolve Ltd. is not publicly available.

Can I buy mAbsolve Ltd. stock?

mAbsolve Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was mAbsolve Ltd.'s last funding round?

mAbsolve Ltd.'s most recent funding round was Seed on March 3, 2020.

Who are the main investors in mAbsolve Ltd.?

Investor information for mAbsolve Ltd. is not publicly disclosed.

Will mAbsolve Ltd. IPO soon?

No public IPO plans have been announced for mAbsolve Ltd..

How can I track mAbsolve Ltd. secondary market activity?

Caplight tracks bids, offers, and trades in mAbsolve Ltd.'s shares on secondary markets.

Firmographic Details

HeadquartersOxford
Employee Range6
Year Founded2019
Last FundingMar 3, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?